Reuters logo
BRIEF-BiondVax and NIH sign clinical trial agreement for phase 2 trial for universal flu vaccine
November 20, 2017 / 2:25 PM / 24 days ago

BRIEF-BiondVax and NIH sign clinical trial agreement for phase 2 trial for universal flu vaccine

Nov 20 (Reuters) - Biondvax Pharmaceuticals Ltd

* BiondVax and NIH sign clinical trial agreement for a phase 2 trial in the U.S. with BiondVax’s universal flu vaccine

* BiondVax Pharmaceuticals - ‍NIAID is submitting IND to FDA, participant recruitment anticipated to begin after end of 2017/18 flu season​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below